<- Go Home

BioGaia AB (publ)

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment offers packaging solutions. It sells its products through distribution partners or through its own distribution channels. The company was incorporated in 1990 and is headquartered in Stockholm, Sweden.

Market Cap

SEK 12.0B

Volume

217.1K

Cash and Equivalents

SEK 446.3M

EBITDA

SEK 454.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

SEK 1.2B

Profit Margin

73.01%

52 Week High

SEK 136.30

52 Week Low

SEK 96.20

Dividend

3.38%

Price / Book Value

10.87

Price / Earnings

34.50

Price / Tangible Book Value

12.66

Enterprise Value

SEK 11.5B

Enterprise Value / EBITDA

24.92

Operating Income

SEK 437.9M

Return on Equity

30.78%

Return on Assets

19.77

Cash and Short Term Investments

SEK 446.3M

Debt

N/A

Equity

SEK 1.1B

Revenue

SEK 1.6B

Unlevered FCF

SEK 231.6M

Sector

Biotechnology

Category

N/A

Company Stock Pitches